Pharma's Almanac: Nice Insight's Content Community

Developing a Toolbox of Functional Bioassays for Optimizing ADCC

Tanvex CDMO’s Anke Hartung, Ph.D., discusses her team’s development of novel analytical tools to assess the enhancement of the antibody-dependent cellular cytoxicity response of an anticancer monoclonal antibody drug.

Agile Cell Supply and Processing to Accelerate Development of the Medicines of the Future

Cell Therapy

Agile Cell Supply and Processing to Accelerate Development of the Medicines of the Future

In this Q&A, OrganaBio’s Chief Executive Officer Justin Irizarry discusses the strategies and operational philosophies driving the company and how it plans to navigate future challenges and opportunities in the rapidly evolving cell therapy landscape.

Ophthalmology

Sep 16, 2024

The Shift from Early- to Late-Phase Ophthalmology Retina Market in 2024: Proactive Planning for Late-Stage Clinical Success

Tracey Roberts, Jennifer Christiansen, Ph.D., and Debra Schaumberg, Sc.D., O.D., all with the PPD™ clinical research business of Thermo Fisher Scientific, discuss the growth and challenges of global, late-stage ophthalmology clinical trials and the key drivers of proactive planning for success.

Process Development

Sep 24, 2024

Economic Benefits of Digital Process Development

DataHow’s Fabian Feidl, Ph.D., discusses how advanced digital tools and strategies, including quality-by-design, hybrid modeling, transfer learning, and digital twins, not only enhance efficiency in process development but also substantially cut costs in manufacturing.

Gene Editing

MegaBulb DNA: a Non-Viral ssDNA Breakthrough Revolutionizing Gene Editing

Touchlight’s Elena Stoyanova, Ph.D., and Tom Adie, Ph.D., explain how the company’s new nonviral MegaBulb DNA (mbDNA) offers a high-purity, synthetic CRISPR ssDNA template that demonstrates remarkable efficiency and minimal toxicity.

Optimized Residual dsRNA Detection for mRNA Therapeutics

RNA

Optimized Residual dsRNA Detection for mRNA Therapeutics

A team of experts from Samsung Biologics discusses the company’s development of a superior ELISA-based method for dsRNA detection that ensures greater accuracy and reliability.

Revolutionizing Autoimmune Disease Management with Soluble Bispecific Receptors

Biopharma

Sep 27, 2024

Revolutionizing Autoimmune Disease Management with Soluble Bispecific Receptors

Fab Biopharma’s Reiner Getz, Ph.D., and Gardiner Smith, J.D. discuss how the company aims to revolutionize the treatment of complex and often life-threatening autoimmune diseases like Sjögren’s disease and lupus with its groundbreaking soluble bispecific receptor therapies

News

Appointment

Prime Therapeutics bolsters its position as industry leader with 10 research studies at AMCP Nexus 2024

Clinical Trials

Harbour BioMed Announces the Phase I Study Results in Combination with Toripalimab in Advanced Melanoma and Other Solid Tumors

Large Molecule

Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis

CDMO

Revolutionary CDMO Wheeler Bio Appoints Patrick Lucy as CEO

ADC

Oct 10, 2024

World ADC San Diego Celebrates 15th Anniversary With Industry-Leading Agenda

Announcement

Oct 08, 2024

Genezen Appoints Mike Wourms as Chief Operations Officer

The Road to the Max: Australia

Top 5

dbDNA

Revolutionizing the Genetic Medicine Landscape with Enzymatic DNA

Top 5

Exposomics

Sep 05, 2024

Transforming Precision Medicine through a High-Resolution Temporal Exposome Platform

RoundTable

View all roundtable

RoundTable

View all roundtable

Now Trending

RNA

Optimized Residual dsRNA Detection for mRNA Therapeutics

Commercialization

Sep 17, 2024

Development Strategies for Overcoming Commercialization Challenges

Mitigating Early Development Risks with Samsung Biologics DEVELOPICK™ Platform

Developability

Sep 04, 2024

Mitigating Early Development Risks with Samsung Biologics DEVELOPICK™ Platform

Transforming Precision Medicine through a High-Resolution Temporal Exposome Platform

Exposomics

Sep 05, 2024

Transforming Precision Medicine through a High-Resolution Temporal Exposome Platform

Cell Therapy

Agile Cell Supply and Processing to Accelerate Development of the Medicines of the Future

Transforming Drug Development through a Female Perspective

Female-Centric

Sep 10, 2024

Transforming Drug Development through a Female Perspective

Nanocarriers to Overcome the Blood–Brain Barrier (BBB)

Drug Delivery

Aug 30, 2024

Nanocarriers to Overcome the Blood–Brain Barrier (BBB)

Gene Editing

MegaBulb DNA: a Non-Viral ssDNA Breakthrough Revolutionizing Gene Editing

DoE for Clone Selection and Process Development to Meet Biosimilar Critical Qualities Attributes and High Productivity

Biosimilars

Sep 12, 2024

DoE for Clone Selection and Process Development to Meet Biosimilar Critical Qualities Attributes and High Productivity

Biopharma

Sep 27, 2024

Revolutionizing Autoimmune Disease Management with Soluble Bispecific Receptors

Building on a Pioneering Biomanufacturing Legacy with Client Centricity

Expansion

Sep 09, 2024

Building on a Pioneering Biomanufacturing Legacy with Client Centricity

Bioassays

Academia CDMO Clinical CRO Drug Discovery Early R&D Excipients / Intermediates Financing Equipment Preclinical CRO Supply Chain Technology

Developing a Toolbox of Functional Bioassays for Optimizing ADCC

Ophthalmology

Sep 16, 2024

The Shift from Early- to Late-Phase Ophthalmology Retina Market in 2024: Proactive Planning for Late-Stage Clinical Success

Process Development

Sep 24, 2024

Economic Benefits of Digital Process Development

Revolutionizing Biologics (and Biology) through a Focus on Women

Women's Health

Jul 09, 2024

Revolutionizing Biologics (and Biology) through a Focus on Women

Biotech

Sep 23, 2024

Five Small Biotechs to Watch: October 2024

Videos

View all videos

Aqueous Cleaning

Dec 05, 2023

The Power of Aqueous Detergents in Critical Cleaning

In this new episode of Pharma's Almanac TV, Michael Moussourakis, Vice President, Technical Marketing and Strategy for Alconox Inc., discusses the enduring benefits of aqueous critical cleaning in terms of efficacy, biodegradability and operator safety and the company's recent release of the 5th edition of their Aqueous Cleaning Handbook.

Aqueous Cleaning

Dec 05, 2023

The Power of Aqueous Detergents in Critical Cleaning

Transforming Market Insights into Growth

Marketing

May 09, 2022

Transforming Market Insights into Growth

Supply Chain

Dec 12, 2023

Rethinking the Pharma/Biopharma Supply Chain to Maximize Resilience

Decentralized Clinical Trials

Nov 17, 2022

The Evolving Role of Remote Monitoring

Meet the Crew

Aug 07, 2024

Assembling the Crew

Preparing to Launch

Aug 07, 2024

Preparing the Yacht for the Race

Stem Cell Therapy

Dec 12, 2023

Designing A Recipe for Stem Cell Therapy Success

Failure to Launch

Aug 07, 2024

Disaster Strikes

Biologics CDMO

Jan 26, 2022

Growing as a Trusted, Dedicated Commercial Biologics CDMO

Building Multiple Platforms to Address Difficult-to-Treat Cancers

Immuno-Oncology

May 24, 2022

Building Multiple Platforms to Address Difficult-to-Treat Cancers

Data Connectivity

Jan 19, 2022

Discussing the Advancements in Oncology

Setting Sail

Aug 07, 2024

Sailing into the Trade Winds

In Focus

Expansion

Sep 09, 2024

Building on a Pioneering Biomanufacturing Legacy with Client Centricity

Transforming the Economics of AAV Manufacture While Optimizing Quality with dbDNA

Synthetic DNA

Jul 02, 2024

Transforming the Economics of AAV Manufacture While Optimizing Quality with dbDNA

Comparability

Aug 26, 2024

Leveraging Risk Assessment for Demonstrating Product Comparability after Manufacturing Process Changes

CDMO Model

Jul 29, 2024

Rethinking the Conventional CDMO Model

Developability

Sep 04, 2024

Mitigating Early Development Risks with Samsung Biologics DEVELOPICK™ Platform

Developability

Aug 26, 2024

Assessing Developability and Designing Advanceable Formulations from the Start

Latest

View all latest

Areas of Interests

A comprehensive market analysis with 110 major company profiles and detailed CDMO pricing information.

Over 60 company profiles covering the leading mRNA and LNP contract manufacturing organizations. Unique pricing comparison for the end-to-end manufacturing process.

Optimize your manufacturing process using 50+ established CDMO overviews and a requisite pricing study for small, mid sized and large manufacturers.

Comprehensive analysis of mammalian cell culture CDMOs including price benchmarking, market trends and over 80 company profiles.

Over 80 company profiles and analysis of leading microbial fermentation CDMO; exclusive market analysis and price comparison.

Understand the emerging ADC market with profiles on 30 notable CDMOs and an analysis of the value chain of mAbs, linkers and payloads. Benchmark with robust manufacturing pricing.

Exclusive pricing from 20+ CDMOs and market insight for pDNA as a reagent for advanced therapies and as a primary therapeutic.

Robust analysis of gene therapy market, includes 50 company profiles of AAV, Lentiviral and non-viral gene therapy CDMOs.

Discover the cell therapy market with unique insights, analysis, and overviews of allogeneic and autologous cell therapy CDMOs.

Over 80 extensive CDMO profiles for an all-encompassing benchmarking report. Exclusive pricing comparison and updated global GMP regulatory landscape

Discover the cell therapy market with unique insights, analysis, and overviews of allogeneic and autologous cell therapy CDMOs.